SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-001914
Filing Date
2022-01-19
Accepted
2022-01-19 08:30:31
Documents
15
Period of Report
2022-01-19
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10032870_8k.htm   iXBRL 8-K 30615
2 EXHIBIT 99.1 brhc10032870_ex99-1.htm EX-99.1 29707
7 image00001.jpg GRAPHIC 4485
  Complete submission text file 0001140361-22-001914.txt   249870

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA adma-20220119.xsd EX-101.SCH 4150
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adma-20220119_def.xml EX-101.DEF 17529
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE adma-20220119_lab.xml EX-101.LAB 26942
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adma-20220119_pre.xml EX-101.PRE 19708
9 EXTRACTED XBRL INSTANCE DOCUMENT brhc10032870_8k_htm.xml XML 5912
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

IRS No.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36728 | Film No.: 22536857
SIC: 2836 Biological Products, (No Diagnostic Substances)